BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20708155)

  • 1. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis.
    Bennecke M; Kriegl L; Bajbouj M; Retzlaff K; Robine S; Jung A; Arkan MC; Kirchner T; Greten FR
    Cancer Cell; 2010 Aug; 18(2):135-46. PubMed ID: 20708155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific p19Arf regulation dictates the response to oncogenic K-ras.
    Young NP; Jacks T
    Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10184-9. PubMed ID: 20479239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways.
    Wang Z; Banerjee S; Ahmad A; Li Y; Azmi AS; Gunn JR; Kong D; Bao B; Ali S; Gao J; Mohammad RM; Miele L; Korc M; Sarkar FH
    PLoS One; 2011; 6(6):e20537. PubMed ID: 21673986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia.
    Williams TM; Lee H; Cheung MW; Cohen AW; Razani B; Iyengar P; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Jun; 279(23):24745-56. PubMed ID: 15044451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescence of human fibroblasts induced by oncogenic Raf.
    Zhu J; Woods D; McMahon M; Bishop JM
    Genes Dev; 1998 Oct; 12(19):2997-3007. PubMed ID: 9765202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer: a multipathway disease.
    Jass JR
    Crit Rev Oncog; 2006 Dec; 12(3-4):273-87. PubMed ID: 17425506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
    Peeper DS; Shvarts A; Brummelkamp T; Douma S; Koh EY; Daley GQ; Bernards R
    Nat Cell Biol; 2002 Feb; 4(2):148-53. PubMed ID: 11812999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16(Ink4a) in melanocyte senescence and differentiation.
    Sviderskaya EV; Hill SP; Evans-Whipp TJ; Chin L; Orlow SJ; Easty DJ; Cheong SC; Beach D; DePinho RA; Bennett DC
    J Natl Cancer Inst; 2002 Mar; 94(6):446-54. PubMed ID: 11904317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressors and oncogenes in cellular senescence.
    Bringold F; Serrano M
    Exp Gerontol; 2000 May; 35(3):317-29. PubMed ID: 10832053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b).
    Malumbres M; Pérez De Castro I; Hernández MI; Jiménez M; Corral T; Pellicer A
    Mol Cell Biol; 2000 Apr; 20(8):2915-25. PubMed ID: 10733595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors.
    Haferkamp S; Scurr LL; Becker TM; Frausto M; Kefford RF; Rizos H
    J Invest Dermatol; 2009 Aug; 129(8):1983-91. PubMed ID: 19212341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo.
    Sansom OJ; Meniel V; Wilkins JA; Cole AM; Oien KA; Marsh V; Jamieson TJ; Guerra C; Ashton GH; Barbacid M; Clarke AR
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14122-7. PubMed ID: 16959882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes.
    Vijayachandra K; Higgins W; Lee J; Glick A
    Mol Carcinog; 2009 Mar; 48(3):181-186. PubMed ID: 18655107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.
    Wang Y; Zhang Z; Lubet R; You M
    Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of lactate-inducible snail protein suppresses oncogene-mediated senescence through p16
    Li X; Zhang Z; Zhang Y; Cao Y; Wei H; Wu Z
    J Exp Clin Cancer Res; 2018 Feb; 37(1):39. PubMed ID: 29482580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.
    Schmitt CA; Fridman JS; Yang M; Lee S; Baranov E; Hoffman RM; Lowe SW
    Cell; 2002 May; 109(3):335-46. PubMed ID: 12015983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
    Suehiro Y; Wong CW; Chirieac LR; Kondo Y; Shen L; Webb CR; Chan YW; Chan AS; Chan TL; Wu TT; Rashid A; Hamanaka Y; Hinoda Y; Shannon RL; Wang X; Morris J; Issa JP; Yuen ST; Leung SY; Hamilton SR
    Clin Cancer Res; 2008 May; 14(9):2560-9. PubMed ID: 18451217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.